Advertisement
BGMS vs BRNS
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BGMS is a StrongBuy and BRNS is a Hold.
BGMS's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for BGMS turned positive on October 13, 2026. Looking at past instances where BGMS's MACD turned positive, the stock continued to rise in 40 of 42 cases over the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 56 of 67 cases where BGMS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.
The Momentum Indicator moved above the 0 level on October 16, 2026. You may want to consider a long position or call options on BGMS as a result. In 72 of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 88%.
BGMS moved above its 50-day moving average on October 16, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for BGMS crossed bullishly above the 50-day moving average on October 21, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 16 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Following a +7.19% 3-day Advance, the price is estimated to grow further. Considering data from situations where BGMS advanced for three days, in 182 of 208 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BGMS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 25 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.873) is normal, around the industry mean (3.055). P/E Ratio (-0.099) is within average values for comparable stocks, (24.278). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.238). Dividend Yield (0.000) settles around the average of (0.066) among similar stocks. P/S Ratio (2.410) is also within normal values, averaging (1.941).
The Tickeron Price Growth Rating for this company is 57 (best 1 - 100 worst), indicating steady price growth. BGMS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BGMS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock worse than average.
BRNS sees its 50-day moving average cross bullishly above its 200-day moving average
The 50-day moving average for BRNS moved above the 200-day moving average on September 28, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on September 22, 2026. You may want to consider a long position or call options on BRNS as a result. In 98 of 116 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.
Bearish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 22 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Aroon Indicator for BRNS entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 44 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.530) is normal, around the industry mean (2.973). P/E Ratio (-0.726) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (2.165) is also within normal values, averaging (438.009).
The Tickeron Price Growth Rating for this company is 49 (best 1 - 100 worst), indicating steady price growth. BRNS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 65 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BRNS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
BGMS | ||
|---|---|---|
OUTLOOK RATING 1..100 | 40 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 25 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 100 | |
PRICE GROWTH RATING 1..100 | 57 | |
P/E GROWTH RATING 1..100 | 98 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| BGMS | BRNS | |
|---|---|---|
| RSI ODDS (%) | N/A | N/A |
| Stochastic ODDS (%) | 1 day ago 84% | 2 days ago 83% |
| Momentum ODDS (%) | 1 day ago 88% | 1 day ago 84% |
| MACD ODDS (%) | 1 day ago 90% | N/A |
| TrendWeek ODDS (%) | 1 day ago 85% | 1 day ago 78% |
| TrendMonth ODDS (%) | 1 day ago 90% | 1 day ago 77% |
| Advances ODDS (%) | 2 days ago 88% | N/A |
| Declines ODDS (%) | 8 days ago 90% | N/A |
| BollingerBands ODDS (%) | N/A | N/A |
| Aroon ODDS (%) | N/A | 1 day ago 88% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BGMS’s FA Score shows that 1 FA rating(s) are green while BRNS’s FA Score has 0 green FA rating(s).
- BGMS’s FA Score: 1 green, 4 red.
- BRNS’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BGMS’s TA Score shows that 6 TA indicator(s) are bullish while BRNS’s TA Score has 2 bullish TA indicator(s).
- BGMS’s TA Score: 6 bullish, 1 bearish.
- BRNS’s TA Score: 2 bullish, 2 bearish.
Price Growth
BGMS (@Building Products) experienced а +7.41% price change this week, while BRNS (@Biotechnology) price change was 0.00% for the same time period.
The average weekly price growth across all stocks in the @Building Products industry was +1.43%. For the same industry, the average monthly price growth was -2.04%, and the average quarterly price growth was -8.84%.
The average weekly price growth across all stocks in the @Biotechnology industry was -1.17%. For the same industry, the average monthly price growth was -18.21%, and the average quarterly price growth was -15.24%.
Reported Earning Dates
BGMS is expected to report earnings on Nov 12, 2026.
BRNS is expected to report earnings on Nov 05, 2026.
Industries' Descriptions
@Building Products (+1.43% weekly)The industry manufactures products used in the construction of residential and commercial buildings. The process involves using materials and other products, and processing them to create finished items such as doors, windows, light fittings, floor coverings, climate control products and other building components and home improvement products. Masco Corporation, Allegion PLC and Lennox International Inc. are major manufacturers of such products.
@Biotechnology (-1.17% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
BRNS and
Correlation & Price change
A.I.dvisor indicates that over the last year, BRNS has been loosely correlated with NGNE. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if BRNS jumps, then NGNE could also see price increases.
| Ticker / NAME | Correlation To BRNS | 1D Price Change % | ||
|---|---|---|---|---|
| BRNS | 100% | N/A | ||
| NGNE - BRNS | 51% Loosely correlated | -6.90% | ||
| NEUP - BRNS | 50% Loosely correlated | N/A | ||
| TARA - BRNS | 35% Loosely correlated | -2.40% | ||
| BGMS - BRNS | 31% Poorly correlated | -5.62% | ||
| ARGX - BRNS | 29% Poorly correlated | -1.61% | ||
More | ||||